We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYNA icon
976
Synaptics
SYNA
$4.35B
$28.4M 0.01%
529,195
-55,560
-10% -$3.82M
CPRT icon
977
Copart
CPRT
$27.1B
$28.4M 0.01%
4,637,872
-61,840
-1% -$347K
SAM icon
978
Boston Beer
SAM
$1.9B
$28.1M 0.01%
164,155
+23,908
+17% +$3.87M
HLI icon
979
Houlihan Lokey
HLI
$8.71B
$28.1M 0.01%
1,254,240
+152,550
+14% +$3.67M
CTS icon
980
CTS Corp
CTS
$1.8B
$27.9M 0.01%
1,559,330
-8,280
-0.5% -$143K
SEE
981
DELISTED
Sealed Air
SEE
$27.9M 0.01%
606,449
+6,905
+1% +$330K
FINL
982
DELISTED
Finish Line
FINL
$27.8M 0.01%
1,376,048
+322,900
+31% +$6.1M
ZOES
983
DELISTED
Zoe's Kitchen, Inc.
ZOES
$27.8M 0.01%
765,693
+3,710
+0.5% +$139K
DST
984
DELISTED
DST Systems Inc.
DST
$27.6M 0.01%
474,576
+22,104
+5% +$1.3M
LVLT
985
DELISTED
Level 3 Communications Inc
LVLT
$27.6M 0.01%
535,842
-10
-0% -$523
ROK icon
986
Rockwell Automation
ROK
$49.6B
$27.5M 0.01%
239,683
-5,227
-2% -$599K
IPG
987
DELISTED
Interpublic Group of Companies
IPG
$27.5M 0.01%
1,191,209
-5,550
-0.5% -$130K
GPC icon
988
Genuine Parts
GPC
$18.6B
$27.5M 0.01%
271,484
-1,190
-0.4% -$115K
ADSK icon
989
Autodesk
ADSK
$52.3B
$27.4M 0.01%
506,973
-817,750
-62% -$47.3M
SIOX
990
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$27.4M 0.01%
266,887
+97,141
+57% +$9.71M
DNB
991
DELISTED
Dun & Bradstreet
DNB
$27.3M 0.01%
224,015
+20,180
+10% +$2.36M
ANDV
992
DELISTED
Andeavor
ANDV
$27.2M 0.01%
362,562
+17,630
+5% +$1.4M
WWD icon
993
Woodward
WWD
$21.3B
$27.1M 0.01%
470,545
+73,795
+19% +$4.08M
LSXMK
994
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$27M 0.01%
+1,149,704
New +$27.4M
WMB icon
995
Williams Companies
WMB
$90.4B
$26.9M 0.01%
1,245,808
+9,200
+0.7% +$185K
AGCO icon
996
AGCO
AGCO
$7.06B
$26.8M 0.01%
568,946
-86,830
-13% -$4.46M
SJI
997
DELISTED
South Jersey Industries, Inc.
SJI
$26.7M 0.01%
845,622
+814,382
+2,607% +$23.4M
PH icon
998
Parker-Hannifin
PH
$133B
$26.6M 0.01%
246,565
-1,440
-0.6% -$161K
DRH icon
999
Diamondrock Hospitality Co
DRH
$2.51B
$26.4M 0.01%
2,927,724
-364,894
-11% -$3.36M
HAYN
1000
DELISTED
Haynes International, Inc.
HAYN
$26.4M 0.01%
822,338
+2,310
+0.3% +$75.3K

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.